---
layout: default
title: Acitretin
description: "Acitretin çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚ä¸­ç­‰è­‰æ“šç­‰ç´š L3ï¼ŒåŒ…å« 4 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 13
evidence_level: L3
indication_count: 4
---

# Acitretin

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L3</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>4</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Acitretinï¼šå¾ä¹¾ç™¬åˆ°é’æ˜¥ç—˜æ–°é©æ‡‰ç—‡æ¢ç´¢

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Acitretin å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Acitretin åŸæœ¬ç”¨æ–¼åš´é‡æ€§ä¹¾ç™¬åŠçš®è†šè§’åŒ–ç—‡ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**é’æ˜¥ç—˜ (acne)** æœ‰æ•ˆï¼Œ
ç›®å‰æœ‰ **1 å€‹è‡¨åºŠè©¦é©—**å’Œ **18 ç¯‡æ–‡ç»**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | åš´é‡æ€§ç‰›çš®ç™¬ã€çš®è†šè§’åŒ–ç—‡ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | acne (disease)ã€pediatric systemic lupus erythematosusã€fetal erythroblastosisã€familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.94% |
| è­‰æ“šç­‰ç´š | L3 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 6 å¼µ |
| å»ºè­°æ±ºç­– | Proceed with Guardrails |



## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. acne (disease)</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.94%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Acitretin å±¬æ–¼ç¬¬äºŒä»£èŠ³é¦™æ—ç¶­ç”Ÿç´  A é…¸è¡ç”Ÿç‰©ï¼ˆretinoidï¼‰ï¼Œå…¶ä¸»è¦ä½œç”¨æ©Ÿè½‰åŒ…æ‹¬ï¼š</p>
<ol>
<li>èª¿ç¯€è§’è³ªç´°èƒåˆ†åŒ–èˆ‡å¢æ®–</li>
<li>æŠ‘åˆ¶çš®è„‚è…ºæ´»æ€§</li>
<li>æŠ—ç™¼ç‚ä½œç”¨</li>
<li>å…ç–«èª¿ç¯€åŠŸèƒ½</li>

</ol>
<p>é’æ˜¥ç—˜çš„ç—…ç†æ©Ÿè½‰æ¶‰åŠçš®è„‚è…ºéåº¦åˆ†æ³Œã€æ¯›å›Šè§’åŒ–ç•°å¸¸ã€ç—¤ç˜¡æ¡¿èŒå¢æ®–åŠç™¼ç‚åæ‡‰ã€‚Retinoids é¡è—¥ç‰©ï¼ˆå¦‚ isotretinoinï¼‰å·²æ˜¯åš´é‡é’æ˜¥ç—˜çš„æ¨™æº–æ²»ç™‚ã€‚</p>

<p>Acitretin èˆ‡ isotretinoin åŒå±¬ retinoidsï¼Œä½† acitretin å‚³çµ±ä¸Šè¼ƒå°‘ç”¨æ–¼é’æ˜¥ç—˜ï¼Œä¸»è¦å› ç‚ºå…¶æŠ‘åˆ¶çš®è„‚è…ºçš„æ•ˆæœè¼ƒ isotretinoin å¼±ã€‚ç„¶è€Œï¼Œæ–‡ç»é¡¯ç¤º acitretin åœ¨ä»¥ä¸‹æƒ…æ³å¯ä½œç‚ºæ›¿ä»£é¸æ“‡ï¼š</p>
<ul>
<li>Isotretinoin æ²»ç™‚å¤±æ•—å¾Œçš„ç¶­æŒç™‚æ³•</li>
<li>åŒ–è†¿æ€§æ±—è…ºç‚ï¼ˆhidradenitis suppurativa / acne inversaï¼‰åˆä½µçµç¯€å›Šè…«å‹é’æ˜¥ç—˜</li>

</ul>
<p>2002 å¹´å€‹æ¡ˆå ±å‘Š (PMID: 12080949) é¡¯ç¤ºï¼Œisotretinoin æ²»ç™‚ç„¡æ•ˆçš„çµç¯€å›Šè…«å‹é’æ˜¥ç—˜æ‚£è€…ï¼Œä½¿ç”¨ acitretin å¾Œç²å¾—é¡¯è‘—æ”¹å–„ã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<table>
<thead>
<tr>
<th>è©¦é©—ç·¨è™Ÿ</th>
<th>éšæ®µ</th>
<th>ç‹€æ…‹</th>
<th>äººæ•¸</th>
<th>ä¸»è¦ç™¼ç¾</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="https://clinicaltrials.gov/study/NCT04663906">NCT04663906</a></td>
<td>N/A</td>
<td>UNKNOWN</td>
<td>300</td>
<td>ç ”ç©¶å£æœ isotretinoinï¼ˆåŒå±¬ retinoidï¼‰åœ¨ COVID-19 æ„ŸæŸ“é¢¨éšªçš„å½±éŸ¿</td>
</tr>
</tbody>
</table>

<p>*è¨»ï¼šç›®å‰ç„¡å°ˆé–€é‡å° acitretin æ²»ç™‚é’æ˜¥ç—˜çš„è¨»å†Šè‡¨åºŠè©¦é©—*</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr>
<th>PMID</th>
<th>å¹´ä»½</th>
<th>é¡å‹</th>
<th>æœŸåˆŠ</th>
<th>ä¸»è¦ç™¼ç¾</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/12080949/">12080949</a></td>
<td>2002</td>
<td>Case Report</td>
<td>Cutis</td>
<td>Isotretinoin ç„¡æ•ˆçš„çµç¯€å›Šè…«å‹é’æ˜¥ç—˜åˆä½µåŒ–è†¿æ€§æ±—è…ºç‚ï¼Œacitretin ç¶­æŒæ²»ç™‚æˆåŠŸ</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/25640693/">25640693</a></td>
<td>2015</td>
<td>Guideline</td>
<td>JEADV</td>
<td>æ­æ´²åŒ–è†¿æ€§æ±—è…ºç‚æ²»ç™‚æŒ‡å¼•ï¼ŒæåŠ acitretin ç‚ºæ²»ç™‚é¸é …</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/29234829/">29234829</a></td>
<td>2018</td>
<td>Review</td>
<td>Der Hautarzt</td>
<td>åŒ–è†¿æ€§æ±—è…ºç‚è—¥ç‰©æ²»ç™‚ï¼šisotretinoin ç™‚æ•ˆæœ‰é™ï¼Œacitretin æ•ˆæœè¼ƒä½³</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/20874789/">20874789</a></td>
<td>2011</td>
<td>Journal Article</td>
<td>Br J Dermatol</td>
<td>25 å¹´ acitretin æ²»ç™‚åŒ–è†¿æ€§æ±—è…ºç‚é•·æœŸè¿½è¹¤ï¼Œç™‚æ•ˆè‰¯å¥½</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/8573927/">8573927</a></td>
<td>1995</td>
<td>Review</td>
<td>Dermatology</td>
<td>Retinoids èˆ‡çš®è„‚è…ºæ´»æ€§ï¼šæ¯”è¼ƒä¸åŒ retinoids çš„æŠ—ç—˜æ•ˆæœ</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/9074840/">9074840</a></td>
<td>1997</td>
<td>Review</td>
<td>Drugs</td>
<td>Retinoids åœ¨çš®è†šç§‘çš„ç¾æ³èˆ‡æœªä¾†ï¼šåŒ…å«ç—¤ç˜¡ç›¸é—œæ‡‰ç”¨</td>
</tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. pediatric systemic lupus erythematosus</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.35%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. fetal erythroblastosis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.28%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.10%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›ç½²è—¥è¼¸å­—ç¬¬022117è™Ÿ | æ–°å®šåº·ç™¬è† å›Š 25mg | è† å›ŠåŠ‘ | åš´é‡æ€§ç‰›çš®ç™¬ã€çš®è†šè§’åŒ–ç—‡ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬022118è™Ÿ | æ–°å®šåº·ç™¬è† å›Š 10mg | è† å›ŠåŠ‘ | åš´é‡æ€§ç‰›çš®ç™¬ã€çš®è†šè§’åŒ–ç—‡ |

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è—¥ç‰©äº¤äº’ä½œç”¨

**Major äº¤äº’ä½œç”¨ï¼š**
- Tetracyclinesï¼ˆDoxycyclineã€Minocyclineã€Tetracyclineï¼‰ï¼šå¢åŠ å‡æ€§è…¦ç˜¤é¢¨éšª
- Vitamin Aï¼šå¢åŠ ç¶­ç”Ÿç´  A éå¤šç—‡é¢¨éšª
- Ethanolï¼ˆé…’ç²¾ï¼‰ï¼šå¯èƒ½å°‡ acitretin è½‰æ›ç‚º etretinateï¼Œå»¶é•·åŠè¡°æœŸè‡³æ•¸æœˆ
- Isotretinoinï¼šç¦æ­¢ä½µç”¨ï¼Œå¢åŠ ç¶­ç”Ÿç´  A æ¯’æ€§
- Methotrexateï¼šå¢åŠ è‚æ¯’æ€§é¢¨éšª
- å£æœé¿å­•è—¥ï¼ˆLevonorgestrelã€Norethisterone ç­‰ï¼‰ï¼šå¯èƒ½é™ä½é¿å­•æ•ˆæœ

**Moderate äº¤äº’ä½œç”¨ï¼š**
- ç£ºèƒºå°¿ç´ é¡é™è¡€ç³–è—¥ï¼ˆGlimepirideã€Glipizide ç­‰ï¼‰ï¼šå¯èƒ½å½±éŸ¿è¡€ç³–æ§åˆ¶
- å…‰æ•æ„Ÿè—¥ç‰©ï¼ˆAminolevulinic acidã€Methoxsalen ç­‰ï¼‰ï¼šå¢åŠ å…‰æ•æ„Ÿåæ‡‰

### é‡è¦è­¦èª
- **çµ•å°ç¦æ­¢æ‡·å­•**ï¼šacitretin å…·æœ‰å¼·çƒˆè‡´ç•¸æ€§ï¼Œè‚²é½¡å©¦å¥³å¿…é ˆæ–¼æ²»ç™‚å‰ã€ä¸­ã€å¾Œä½¿ç”¨æœ‰æ•ˆé¿å­•æªæ–½
- å› å¯èƒ½è½‰æ›ç‚º etretinateï¼Œ**åœè—¥å¾Œéœ€é¿å­•è‡³å°‘ 3 å¹´**
- **ç¦æ­¢é£²é…’**ï¼šé…’ç²¾æœƒä¿ƒé€² acitretin è½‰æ›ç‚ºé•·æ•ˆ etretinate
- å®šæœŸç›£æ¸¬è‚åŠŸèƒ½åŠè¡€è„‚

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Alcoholism** ğŸŸ¡ Moderate
- æ‡‰é¿å…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**ç³–å°¿ç—…** ğŸŸ¡ Moderate
- éœ€å¯†åˆ‡ç›£æ¸¬ã€‚

**Toxic Optic Neuropathy** ğŸŸ¡ Moderate
- å¿…è¦æ™‚æ‡‰åœæ­¢æ²»ç™‚ã€‚

**Hyperlipidemias** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚éœ€å¯†åˆ‡ç›£æ¸¬ã€‚

**è‚è‡Ÿç–¾ç—…** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**è…è‡Ÿç–¾ç—…** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**Intracranial Hypertension** ğŸŸ¢ Minor
- å‡ºç¾ç—‡ç‹€æ™‚æ‡‰è€ƒæ…®åœè—¥ã€‚

**Mental Disorders** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šThe use of retinoids, primarily isotretinoin, has been associated with causing depression, psychosis and rarely, suicidal ideation...

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¢ Minor
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚
- å»ºè­°ï¼šè«‹è«®è©¢é†«å¸«æˆ–è—¥å¸«äº†è§£è©³ç´°å»ºè­°ã€‚


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šProceed with Guardrails**

**ç†ç”±ï¼š**
Acitretin èˆ‡ isotretinoin åŒå±¬ retinoidsï¼Œå…·æœ‰ç›¸ä¼¼çš„æŠ—è§’åŒ–åŠæŠ—ç™¼ç‚æ©Ÿè½‰ã€‚æ–‡ç»é¡¯ç¤ºå…¶åœ¨ isotretinoin æ²»ç™‚å¤±æ•—æˆ–éœ€é•·æœŸç¶­æŒæ²»ç™‚çš„é’æ˜¥ç—˜æ‚£è€…ä¸­æœ‰æ‡‰ç”¨åƒ¹å€¼ã€‚ç‰¹åˆ¥æ˜¯åœ¨åŒ–è†¿æ€§æ±—è…ºç‚åˆä½µé’æ˜¥ç—˜çš„æƒ…æ³ä¸‹ï¼Œacitretin å¯èƒ½æ¯” isotretinoin æ›´æœ‰æ•ˆã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- æ’é™¤æ‡·å­•å¯èƒ½æ€§ï¼Œè‚²é½¡å©¦å¥³éœ€ä½¿ç”¨å…©ç¨®æœ‰æ•ˆé¿å­•æ–¹æ³•
- å®Œå…¨ç¦æ­¢é£²é…’
- å®šæœŸç›£æ¸¬è‚åŠŸèƒ½ï¼ˆALTã€ASTï¼‰åŠè¡€è„‚ï¼ˆTGã€Cholesterolï¼‰
- é¿å…ä½µç”¨ç¶­ç”Ÿç´  A è£œå……åŠ‘
- é¿å…ä½µç”¨å››ç’°é»´ç´ é¡æŠ—ç”Ÿç´ 
- è¨­è¨ˆ RCT æ¯”è¼ƒ acitretin èˆ‡ isotretinoin åœ¨ä¸åŒé¡å‹é’æ˜¥ç—˜çš„ç™‚æ•ˆ

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Vinorelbine]({{ "/drugs/vinorelbine/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Interferon Beta-1B]({{ "/drugs/interferon_beta-1b/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Lornoxicam]({{ "/drugs/lornoxicam/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Amcinonide]({{ "/drugs/amcinonide/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Human Immunoglobulin G]({{ "/drugs/human_immunoglobulin_g/" | relative_url }}) - è­‰æ“šç­‰ç´š L3

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Acitretinè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/acitretin/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_acitretin,
  title = {Acitretinè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/acitretin/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
